| [1] |
谢幸，苟文丽. 妇产科学[M]. 8版. 北京： 人民卫生出版社，2013: 126-129.
|
| [2] |
朱晓童，孔祥，郑英. 介入治疗在前置胎盘合并胎盘植入剖宫产分娩中应用的研究进展 [J/CD]. 中华妇幼临床医学杂志(电子版), 2017, 13(2): 240-243.
|
| [3] |
张方圆，孔祥，王志学. 胎盘植入的产前诊断[J]. 现代妇产科进展，2015, 24(9): 708-710.
|
| [4] |
张力，李萍，何国琳，等. 经腹彩色超声多普勒在前置胎盘并发胎盘植入诊断中的价值[J]．中华妇产科杂志，2006, 41(12): 799-802.
|
| [5] |
左琴，黄淑晖，刘淮. 预测胎盘植入血清学指标研究进展[J]. 江西医药，2014, 49(8): 781-784.
|
| [6] |
Ophir E, Tendler R, Odeh M, et al. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta[J]. Am J Obstet Gynecol, 1999, 180(4): 1039-1040.
|
| [7] |
陈宏霞，曹伍兰. 血清肌酸激酶及同工酶在胎盘植入中的诊断价值[J]. 中国实用妇科与产科杂志，2008, 24(9): 686-687.
|
| [8] |
孙江川，董晓静，刘建，等. 胎盘植入产妇血清肌酸激酶的变化[J]. 实用妇产科杂志，2006, 22(10): 614-615.
|
| [9] |
Ersoy AO, Oztas E, Ozler S, et al. Can venous ProBNP levels predict placenta accreta? [J]. J Matern Fetal Neonatal Med, 2016, 29(24): 4020-4024.
|
| [10] |
金日男，许红雁，钟永红，等. 血清甲胎蛋白联合彩色超声检查在胎盘植入产前诊断中的价值[J]. 现代妇产科进展，2016, 25(8): 611-613, 616.
|
| [11] |
Kapoor DS, Tincello DG, Kingston RE. Life-threatening obstetric haemorrhage in second trimester from a placenta percreta with raised alpha-fetoprotein levels[J]. J Obstet Gynaecol, 2003, 23(5): 570-571.
|
| [12] |
Sharony R, Dayan D, Kidron D, et al.Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications? [J]. Arch Gynecol Obstet, 2016, 293(4)：767-770.
|
| [13] |
王林琳，杜娟. 神经管缺陷的产前诊断及宫内治疗研究进展[J/CD]. 中国产前诊断杂志(电子版), 2013, 5(1): 23-27.
|
| [14] |
雷晓真，黄淑晖，郑九生，等. 超声联合甲胎蛋白检测预测凶险型前置胎盘合并胎盘植入的临床价值[J]. 中国妇幼保健，2015, 30(18): 2940-2943.
|
| [15] |
彭海燕．多普勒超声、甲胎蛋白与人绒毛膜促性腺激素对前置胎盘植入预测作用分析[J]．山西医药杂志，2017, 46(6)：638-640.
|
| [16] |
刘彬，高素娟，张娜，等. 核磁共振结合血清甲胎蛋白、肌酸激酶水平诊断凶险型前置胎盘合并胎盘植入的价值[J]. 中国妇幼保健，2018, 33(6): 1409-1412.
|
| [17] |
倪雪梅，赖微，朱巧英，等. 彩超联合甲胎蛋白在孕晚期预测凶险性前置胎盘合并胎盘植入的应用分析[J]. 中国计划生育和妇产科，2017, 9(8): 53-56.
|
| [18] |
陈柯艺，杨洁霞. 妊娠相关血浆蛋白A与不良妊娠结局相关性的研究进展[J]. 中国优生与遗传杂志，2014, 22(1): 3-5.
|
| [19] |
刘微，赵艳晖，戚洁. PAPP-A对相关病理妊娠的预测价值评价[J]. 中国妇幼保健，2016, 31(14): 2988-2990.
|
| [20] |
Desai N, Krantz D, Roman A，et al. Elevated first trimester PAPP: a is associated with increased risk of placenta accreta[J]. Prenat Diagn，2014，34(2)：159-162.
|
| [21] |
黄一颖，段涛. 母血中胎儿DNA预测前置胎盘合并黏连的探讨[J]. 现代妇产科进展，2006, 15(11): 854-857.
|
| [22] |
Sekizawa A, Jimbo M, Saito H, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta[J]. Clin Chem, 2002, 48(2): 353-354.
|
| [23] |
汤冬玲. 母体循环胎儿DNA的生物学特点与前置胎盘的关联研究[J]. 中国优生与遗传杂志，2016, 24(6): 58-59, 78.
|
| [24] |
Samuel A, Bonanno C, Oliphant A, et al. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study[J]. Prenat Diagn, 2013, 33(11): 1050-1053.
|
| [25] |
El Behery MM, Rasha LE, El Alfy Y. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta[J]. Int J Gynaecol Obstet, 2010, 109(1): 30-33.
|
| [26] |
Kawashima A, Sekizawa A, Ventura W, et al. Increased levels of cell-free human placental lactogen mRNA at 28-32 gestational weeks in plasma of pregnant women with placenta previa and invasive placenta[J]. Reprod Sci, 2014, 21(2): 215-220.
|
| [27] |
Zhou J, Li J, Yan P, et al. Maternal plasma levels of cell-free β-hCG mRNA as a prenatal diagnostic indicator of placenta accrete[J]. Placenta, 2014, 35(9): 691-695.
|
| [28] |
周军. 母体血浆游离胎盘mRNA用于胎盘植入患者的产前诊断[D]. 济南：山东大学，2015.
|
| [29] |
Li N, Yang T, Liu C, et al. Feasibility of infrarenal abdominal aorta balloon occlusion in pernicious placenta previa coexisting with placenta accrete [J]. Biomed Res Int, 2018, 2018: 4596189.
|
| [30] |
Nonaka T, Yoshida K, Yamaguchi M, et al. Case with pyoderma gangrenosum abruptly emerging around the wound of cesarean section for placenta previa with placenta accrete [J]. J Obstet Gynaecol Res, 2016, 42(9): 1190-1193.
|
| [31] |
吴英，余艳红，李青，等. 子痫前期患者胎盘色素上皮衍生因子和血管内皮生长因子的表达[J]. 中国实用妇科与产科杂志，2013, 29(6): 459-463
|
| [32] |
Lash GE, Pitman H, Morgan HL, et al. Decidual macrophages: key regulators of vascular remodeling in human pregnancy [J]. J Leukoc Biol, 2016, 100(2): 315-325.
|
| [33] |
Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast[J]. Am J Obstet Gynecol, 2011, 204(5): 411.e1-411.e11.
|
| [34] |
Biberoglu E, Kirbas A, Daglar K, et al. Serum angiogenic profile in abnormal placentation[J]. J Matern Fetal Neonatal Med, 2016, 29(19): 3193-3197.
|
| [35] |
李蕊，林靓，杨茵，等. 色素上皮衍生因子对植入型凶险性前置胎盘形成的影响及机制研究[J]. 中国妇幼保健，2016, 31(19): 3942-3945.
|
| [36] |
黄艳萍，梁春燕. 综合指标检测在凶险型前置胎盘早期诊断中的应用[J]. 吉林医学，2013, 34(33): 6900-6901.
|
| [37] |
赵雅堃. 血清外体RNA及AFP对胎盘植入的临床诊断价值[D]. 保定：河北大学，2017.
|